Patients with multivessel or left main coronary artery disease in optimal physical and mental health fare much better with CABG surgery than PCI over long-term follow-up, an analysis of the SYNTAX ...
Elderly patients with complex geriatric conditions and left main or multivessel coronary artery disease who experience an acute coronary syndrome—particularly NSTEMI or unstable angina—fare ...
After undergoing coronary artery bypass grafting (CABG), a patient was sent home on clopidogrel (Plavix) but not aspirin. When he presented to the emergency department with acute coronary syndrome ...
Perioperative morbidity and mortality were reduced with off-pump vs on-pump coronary artery bypass grafting, though survival ...
Please provide your email address to receive an email when new articles are posted on . The use of CABG has declined dramatically in MI admissions, particularly in STEMI, according to a presentation ...
The relative benefits of coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) continue to be actively debated and analyzed. A recent meta-analysis of individual data from 7 ...
Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin alone, ...
Real-World Analysis Shows Statistically Significant Reduction in Severe Bleeding and Transfusion Needs in CABG Patients on the Blood Thinner, Ticagrelor, with CytoSorbents Therapy Presented by ...
Valdecoxib is not approved for use in the treatment of postoperative pain of any type. Valdecoxib is a cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drug (NSAID) that is indicated in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results